Unfolded Protein Response Inhibition Reduces Middle East Respiratory Syndrome Coronavirus-Induced Acute Lung Injury

ABSTRACT Tissue- and cell-specific expression patterns are highly variable within and across individuals, leading to altered host responses after acute virus infection. Unraveling key tissue-specific response patterns provides novel opportunities for defining fundamental mechanisms of virus-host int...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Amy C. Sims, Hugh D. Mitchell, Lisa E. Gralinski, Jennifer E. Kyle, Kristin E. Burnum-Johnson, Mariam Lam, M. Leslie Fulcher, Ande West, Richard D. Smith, Scott H. Randell, Thomas O. Metz, Timothy P. Sheahan, Katrina M. Waters, Ralph S. Baric
Formato: article
Lenguaje:EN
Publicado: American Society for Microbiology 2021
Materias:
Acceso en línea:https://doaj.org/article/a299fa7ab51f41d792827fb0f696c144
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:a299fa7ab51f41d792827fb0f696c144
record_format dspace
spelling oai:doaj.org-article:a299fa7ab51f41d792827fb0f696c1442021-11-10T18:37:51ZUnfolded Protein Response Inhibition Reduces Middle East Respiratory Syndrome Coronavirus-Induced Acute Lung Injury10.1128/mBio.01572-212150-7511https://doaj.org/article/a299fa7ab51f41d792827fb0f696c1442021-08-01T00:00:00Zhttps://journals.asm.org/doi/10.1128/mBio.01572-21https://doaj.org/toc/2150-7511ABSTRACT Tissue- and cell-specific expression patterns are highly variable within and across individuals, leading to altered host responses after acute virus infection. Unraveling key tissue-specific response patterns provides novel opportunities for defining fundamental mechanisms of virus-host interaction in disease and the identification of critical tissue-specific networks for disease intervention in the lung. Currently, there are no approved therapeutics for Middle East respiratory syndrome coronavirus (MERS-CoV) patients, and little is understood about how lung cell types contribute to disease outcomes. MERS-CoV replicates equivalently in primary human lung microvascular endothelial cells (MVE) and fibroblasts (FB) and to equivalent peak titers but with slower replication kinetics in human airway epithelial cell cultures (HAE). However, only infected MVE demonstrate observable virus-induced cytopathic effect. To explore mechanisms leading to reduced MVE viability, donor-matched human lung MVE, HAE, and FB were infected, and their transcriptomes, proteomes, and lipidomes were monitored over time. Validated functional enrichment analysis demonstrated that MERS-CoV-infected MVE were dying via an unfolded protein response (UPR)-mediated apoptosis. Pharmacologic manipulation of the UPR in MERS-CoV-infected primary lung cells reduced viral titers and in male mice improved respiratory function with accompanying reductions in weight loss, pathological signatures of acute lung injury, and times to recovery. Systems biology analysis and validation studies of global kinetic transcript, protein, and lipid data sets confirmed that inhibition of host stress pathways that are differentially regulated following MERS-CoV infection of different tissue types can alleviate symptom progression to end-stage lung disease commonly seen following emerging coronavirus outbreaks. IMPORTANCE Middle East respiratory syndrome coronavirus (MERS-CoV) causes severe atypical pneumonia in infected individuals, but the underlying mechanisms of pathogenesis remain unknown. While much has been learned from the few reported autopsy cases, an in-depth understanding of the cells targeted by MERS-CoV in the human lung and their relative contribution to disease outcomes is needed. The host response in MERS-CoV-infected primary human lung microvascular endothelial (MVE) cells and fibroblasts (FB) was evaluated over time by analyzing total RNA, proteins, and lipids to determine the cellular pathways modulated postinfection. Findings revealed that MERS-CoV-infected MVE cells die via apoptotic mechanisms downstream of the unfolded protein response (UPR). Interruption of enzymatic processes within the UPR in MERS-CoV-infected male mice reduced disease symptoms, virus-induced lung injury, and time to recovery. These data suggest that the UPR plays an important role in MERS-CoV infection and may represent a host target for therapeutic intervention.Amy C. SimsHugh D. MitchellLisa E. GralinskiJennifer E. KyleKristin E. Burnum-JohnsonMariam LamM. Leslie FulcherAnde WestRichard D. SmithScott H. RandellThomas O. MetzTimothy P. SheahanKatrina M. WatersRalph S. BaricAmerican Society for MicrobiologyarticleMERS-CoVacute lung injuryprimary human lung cellsmicrovascular endothelial cellsfibroblastsapoptosisMicrobiologyQR1-502ENmBio, Vol 12, Iss 4 (2021)
institution DOAJ
collection DOAJ
language EN
topic MERS-CoV
acute lung injury
primary human lung cells
microvascular endothelial cells
fibroblasts
apoptosis
Microbiology
QR1-502
spellingShingle MERS-CoV
acute lung injury
primary human lung cells
microvascular endothelial cells
fibroblasts
apoptosis
Microbiology
QR1-502
Amy C. Sims
Hugh D. Mitchell
Lisa E. Gralinski
Jennifer E. Kyle
Kristin E. Burnum-Johnson
Mariam Lam
M. Leslie Fulcher
Ande West
Richard D. Smith
Scott H. Randell
Thomas O. Metz
Timothy P. Sheahan
Katrina M. Waters
Ralph S. Baric
Unfolded Protein Response Inhibition Reduces Middle East Respiratory Syndrome Coronavirus-Induced Acute Lung Injury
description ABSTRACT Tissue- and cell-specific expression patterns are highly variable within and across individuals, leading to altered host responses after acute virus infection. Unraveling key tissue-specific response patterns provides novel opportunities for defining fundamental mechanisms of virus-host interaction in disease and the identification of critical tissue-specific networks for disease intervention in the lung. Currently, there are no approved therapeutics for Middle East respiratory syndrome coronavirus (MERS-CoV) patients, and little is understood about how lung cell types contribute to disease outcomes. MERS-CoV replicates equivalently in primary human lung microvascular endothelial cells (MVE) and fibroblasts (FB) and to equivalent peak titers but with slower replication kinetics in human airway epithelial cell cultures (HAE). However, only infected MVE demonstrate observable virus-induced cytopathic effect. To explore mechanisms leading to reduced MVE viability, donor-matched human lung MVE, HAE, and FB were infected, and their transcriptomes, proteomes, and lipidomes were monitored over time. Validated functional enrichment analysis demonstrated that MERS-CoV-infected MVE were dying via an unfolded protein response (UPR)-mediated apoptosis. Pharmacologic manipulation of the UPR in MERS-CoV-infected primary lung cells reduced viral titers and in male mice improved respiratory function with accompanying reductions in weight loss, pathological signatures of acute lung injury, and times to recovery. Systems biology analysis and validation studies of global kinetic transcript, protein, and lipid data sets confirmed that inhibition of host stress pathways that are differentially regulated following MERS-CoV infection of different tissue types can alleviate symptom progression to end-stage lung disease commonly seen following emerging coronavirus outbreaks. IMPORTANCE Middle East respiratory syndrome coronavirus (MERS-CoV) causes severe atypical pneumonia in infected individuals, but the underlying mechanisms of pathogenesis remain unknown. While much has been learned from the few reported autopsy cases, an in-depth understanding of the cells targeted by MERS-CoV in the human lung and their relative contribution to disease outcomes is needed. The host response in MERS-CoV-infected primary human lung microvascular endothelial (MVE) cells and fibroblasts (FB) was evaluated over time by analyzing total RNA, proteins, and lipids to determine the cellular pathways modulated postinfection. Findings revealed that MERS-CoV-infected MVE cells die via apoptotic mechanisms downstream of the unfolded protein response (UPR). Interruption of enzymatic processes within the UPR in MERS-CoV-infected male mice reduced disease symptoms, virus-induced lung injury, and time to recovery. These data suggest that the UPR plays an important role in MERS-CoV infection and may represent a host target for therapeutic intervention.
format article
author Amy C. Sims
Hugh D. Mitchell
Lisa E. Gralinski
Jennifer E. Kyle
Kristin E. Burnum-Johnson
Mariam Lam
M. Leslie Fulcher
Ande West
Richard D. Smith
Scott H. Randell
Thomas O. Metz
Timothy P. Sheahan
Katrina M. Waters
Ralph S. Baric
author_facet Amy C. Sims
Hugh D. Mitchell
Lisa E. Gralinski
Jennifer E. Kyle
Kristin E. Burnum-Johnson
Mariam Lam
M. Leslie Fulcher
Ande West
Richard D. Smith
Scott H. Randell
Thomas O. Metz
Timothy P. Sheahan
Katrina M. Waters
Ralph S. Baric
author_sort Amy C. Sims
title Unfolded Protein Response Inhibition Reduces Middle East Respiratory Syndrome Coronavirus-Induced Acute Lung Injury
title_short Unfolded Protein Response Inhibition Reduces Middle East Respiratory Syndrome Coronavirus-Induced Acute Lung Injury
title_full Unfolded Protein Response Inhibition Reduces Middle East Respiratory Syndrome Coronavirus-Induced Acute Lung Injury
title_fullStr Unfolded Protein Response Inhibition Reduces Middle East Respiratory Syndrome Coronavirus-Induced Acute Lung Injury
title_full_unstemmed Unfolded Protein Response Inhibition Reduces Middle East Respiratory Syndrome Coronavirus-Induced Acute Lung Injury
title_sort unfolded protein response inhibition reduces middle east respiratory syndrome coronavirus-induced acute lung injury
publisher American Society for Microbiology
publishDate 2021
url https://doaj.org/article/a299fa7ab51f41d792827fb0f696c144
work_keys_str_mv AT amycsims unfoldedproteinresponseinhibitionreducesmiddleeastrespiratorysyndromecoronavirusinducedacutelunginjury
AT hughdmitchell unfoldedproteinresponseinhibitionreducesmiddleeastrespiratorysyndromecoronavirusinducedacutelunginjury
AT lisaegralinski unfoldedproteinresponseinhibitionreducesmiddleeastrespiratorysyndromecoronavirusinducedacutelunginjury
AT jenniferekyle unfoldedproteinresponseinhibitionreducesmiddleeastrespiratorysyndromecoronavirusinducedacutelunginjury
AT kristineburnumjohnson unfoldedproteinresponseinhibitionreducesmiddleeastrespiratorysyndromecoronavirusinducedacutelunginjury
AT mariamlam unfoldedproteinresponseinhibitionreducesmiddleeastrespiratorysyndromecoronavirusinducedacutelunginjury
AT mlesliefulcher unfoldedproteinresponseinhibitionreducesmiddleeastrespiratorysyndromecoronavirusinducedacutelunginjury
AT andewest unfoldedproteinresponseinhibitionreducesmiddleeastrespiratorysyndromecoronavirusinducedacutelunginjury
AT richarddsmith unfoldedproteinresponseinhibitionreducesmiddleeastrespiratorysyndromecoronavirusinducedacutelunginjury
AT scotthrandell unfoldedproteinresponseinhibitionreducesmiddleeastrespiratorysyndromecoronavirusinducedacutelunginjury
AT thomasometz unfoldedproteinresponseinhibitionreducesmiddleeastrespiratorysyndromecoronavirusinducedacutelunginjury
AT timothypsheahan unfoldedproteinresponseinhibitionreducesmiddleeastrespiratorysyndromecoronavirusinducedacutelunginjury
AT katrinamwaters unfoldedproteinresponseinhibitionreducesmiddleeastrespiratorysyndromecoronavirusinducedacutelunginjury
AT ralphsbaric unfoldedproteinresponseinhibitionreducesmiddleeastrespiratorysyndromecoronavirusinducedacutelunginjury
_version_ 1718439803414904832